China Shineway Pharmaceutical Group Limited (HKG:2877)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.20
+0.56 (6.48%)
At close: Mar 27, 2026
Market Cap6.95B +7.0%
Revenue (ttm)3.49B -17.0%
Net Income1.06B +13.1%
EPS1.40 +13.3%
Shares Out755.40M
PE Ratio6.56
Forward PE7.34
Dividend0.51 (5.49%)
Ex-Dividend DateMay 4, 2026
Volume4,544,000
Average Volume991,703
Open8.65
Previous Close8.64
Day's Range8.60 - 9.46
52-Week Range6.96 - 10.01
Beta0.87
RSI52.07
Earnings DateMar 27, 2026

About HKG:2877

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Sector Healthcare
Founded 2002
Employees 2,867
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2877
Full Company Profile

Financial Performance

In 2025, HKG:2877's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements